📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
35
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for KALV.
💹 Market Data
Market Cap$1.43B
Shares Outstanding53.24M
Float38.19M
Cash$285.03M
Debt$284.31M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 7.9% shares (2025Q4 vs prior)
162 institutional holders · 68.16M shares
#1
VR ADVISER, LLC
6.73M shares
#2
Frazier Life Sciences Management, L.P.
5.04M shares
#3
SUVRETTA CAPITAL MANAGEMENT, LLC
4.77M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest15.16M
Days to Cover1.8
% of Float39.7%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Apr 01, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2015
4
INSIDER TRANSACTION
Apr 20, 2026
4
INSIDER TRANSACTION
Apr 20, 2026
4
INSIDER TRANSACTION
Apr 20, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for KALV
📊 KALV FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 KALV Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.